Showing results (311-320 of 451) with videos related to
Sort By:
Pageof 46
Bulletin Du Cancer|December 18, 2021
[DESCAR-T, a nationwide registry for patient treated by CAR-T Cells in France]Florence Broussais, Jacques Olivier Bay, Nicolas Boissel, et al.Blood|June 25, 2016
T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cellsImane Azzaoui, Fabrice Uhel, Delphine Rossille, et al.Haematologica|April 9, 2026
Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA studyAxel André, Estelle Bourbon, Guillaume Cartron, et al.Haematologica|June 11, 2026
Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphomaVincent Guiraud, Clotilde Bravetti, Amélie Guihot, et al.Blood|December 25, 2016
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profilingJune H Myklebust, Joshua Brody, Holbrook E Kohrt, et al.Nature Communications|April 26, 2026
Trap-assisted circularly polarized organic photodetectorHongki Kim, Zhuoran Qiao, Marie Houot, et al.Haematologica|May 7, 2013
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphomaEmmanuel Bachy, Roch Houot, Franck Morschhauser, et al.Leukemia & Lymphoma|August 24, 2023
Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphomaAgathe Vély, Marie-Anne Couturier, Pascal Delepine, et al.Journal of the American Chemical Society|July 2, 2026
Photocatalytic Controlled Halodefluorination of Perfluoroalkyl Compounds Using N-ArylphenothiazinesMichael G J Doyle, Maria Elgaard Jespersen, Shana Noureen, et al.British Journal of Haematology|March 25, 2016
A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphomaBertrand Coiffier, Catherine Thieblemont, Sophie de Guibert, et al.Pageof 46